Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) to Ring The Nasdaq Stock Market Closing Bell
Jan 04, 2018 23:13 pm UTC| Business
ADVISORY, Jan. 04, 2018 -- What: Rocket Pharmaceuticals, Inc. (Nasdaq:RCKT), a leading U.S.-based multi-platform gene therapy company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion,...
InterDigital to Present at 20th Annual Needham Growth Conference
Jan 04, 2018 23:13 pm UTC| Business
WILMINGTON, Del., Jan. 04, 2018 -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that the company will be presenting at the 20th Annual Needham Growth Conference...
Administration Demonstrates Sound Planning Strategy for Future Domestic Oil and Gas Development
Jan 04, 2018 23:13 pm UTC| Business
Houston, TX (US), Jan. 04, 2018 -- Nikki Martin, President of the International Association of Geophysical Contractors (IAGC), today issued the following statement regarding the Interior Department’s 2019-2024 OCS Oil...
Jan 04, 2018 23:13 pm UTC| Business
INDIANAPOLIS, Jan. 04, 2018 -- Kite Realty Group Trust (NYSE:KRG) (the “Company”) announced today that David Buell has been promoted to the role of Senior Vice President, Chief Accounting Officer, effective January 1,...
Jan 04, 2018 23:13 pm UTC| Business
WASHINGTON, Jan. 04, 2018 -- Washington REIT (Washington Real Estate Investment Trust) (NYSE:WRE), a leading owner of commercial and multifamily properties in the Washington, DC area, will announce 4th Quarter 2017...
ABM to Webcast 2018 Investor Day
Jan 04, 2018 23:13 pm UTC| Business
NEW YORK, Jan. 04, 2018 -- ABM (NYSE:ABM), a leading provider of facility solutions, today announced that it will host its Investor Day on Thursday, January 18, 2018 in New York City, beginning at approximately 9:00...
Atara Biotherapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 04, 2018 23:13 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2018 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral...